Quality of Regulatory Decision-Making Practices: Issues Facing Companies and Agencies

被引：0
|
作者：
Magdalena Bujar
Neil McAuslane
Sam Salek
Stuart Walker
机构：
[1] Centre for Innovation in Regulatory Science (CIRS),Department of Pharmacy, Pharmacology & Postgraduate Medicine
[2] University of Hertfordshire,School of Pharmacy and Pharmaceutical Sciences
[3] Institute for Medicines Development,undefined
[4] Cardiff University,undefined
来源：
Therapeutic Innovation & Regulatory Science | 2016年 / 50卷
关键词：
quality decision making; framework; new drug application; submission and approval; regulatory agency;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：487 / 495
页数：8
相关论文
共 50 条
  • [1] Quality of Regulatory Decision-Making Practices: Issues Facing Companies and Agencies
    Bujar, Magdalena
    McAuslane, Neil
    Salek, Sam
    Walker, Stuart
    [J]. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2016, 50 (04) : 487 - 495
  • [2] Quality Decision Making in Health Technology Assessment: Issues Facing Companies and Agencies
    Magdalena Bujar
    Neil McAuslane
    Stuart R. Walker
    Sam Salek
    [J]. Therapeutic Innovation & Regulatory Science, 2020, 54 : 275 - 282
  • [3] Quality Decision Making in Health Technology Assessment: Issues Facing Companies and Agencies
    Bujar, Magdalena
    McAuslane, Neil
    Walker, Stuart R.
    Salek, Sam
    [J]. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2020, 54 (02) : 275 - 282
  • [4] Quality Decision-Making Practices in Pharmaceutical Companies and Regulatory Authorities: Current and Proposed Approaches to Its Documentation
    Magdalena Bujar
    Neil McAuslane
    Patricia Connelly
    Stuart R. Walker
    [J]. Therapeutic Innovation & Regulatory Science, 2020, 54 : 1404 - 1415
  • [5] Quality Decision-Making Practices in Pharmaceutical Companies and Regulatory Authorities: Current and Proposed Approaches to Its Documentation
    Bujar, Magdalena
    McAuslane, Neil
    Connelly, Patricia
    Walker, Stuart R.
    [J]. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2020, 54 (06) : 1404 - 1415
  • [6] ROLE OF REGULATORY AGENCIES IN RISK-BENEFIT DECISION-MAKING
    COOPER, RM
    [J]. FOOD AND DRUG LAW JOURNAL, 1978, 33 (12): : 755 - 773
  • [7] Research on financing decision-making practices in Croatian companies
    Pecina, Ena
    [J]. EKONOMSKI PREGLED, 2024, 75 (03): : 261 - 275
  • [8] DISCRETIONARY DECISION-MAKING IN THE REGULATORY AGENCIES - A CONCEPTUAL-FRAMEWORK
    GIFFORD, DJ
    [J]. SOUTHERN CALIFORNIA LAW REVIEW, 1983, 57 (01) : 101 - 135
  • [9] Regulatory Review: How Do Agencies Ensure the Quality of Decision Making?
    Liberti, L.
    McAuslane, N.
    Patel, P.
    Breckenridge, A.
    Eichler, H. G.
    Peterson, R.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 94 (03) : 305 - 308
  • [10] Political Independence, Accountability, and the Quality of Regulatory Decision-Making
    Koop, Christel
    Hanretty, Chris
    [J]. COMPARATIVE POLITICAL STUDIES, 2018, 51 (01) : 38 - 75
12345